These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 15093554
1. Type 1 and type 2 tumor infiltrating effector cell subpopulations in progressive breast cancer. Reome JB, Hylind JC, Dutton RW, Dobrzanski MJ. Clin Immunol; 2004 Apr; 111(1):69-81. PubMed ID: 15093554 [Abstract] [Full Text] [Related]
2. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix. Santin AD, Ravaggi A, Bellone S, Pecorelli S, Cannon M, Parham GP, Hermonat PL. Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133 [Abstract] [Full Text] [Related]
3. Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating endogenous CD49b-expressing CD4 and CD8 T effector cell subpopulations producing IL-10. Dobrzanski MJ, Reome JB, Hylind JC, Rewers-Felkins KA, Abdulsamad K, Adams SL. Immunol Invest; 2008 Jun; 37(4):315-38. PubMed ID: 18569073 [Abstract] [Full Text] [Related]
4. Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating differentiated T cell localization, activation and chemokine production in established breast cancer. Dobrzanski MJ, Reome JB, Hylind JC, Rewers-Felkins KA, Abulsamad K, Adams SL. Clin Immunol; 2008 Aug; 128(2):205-18. PubMed ID: 18511346 [Abstract] [Full Text] [Related]
6. AsialoGM1+CD8+ central memory-type T cells in unimmunized mice as novel immunomodulator of IFN-gamma-dependent type 1 immunity. Kosaka A, Wakita D, Matsubara N, Togashi Y, Nishimura S, Kitamura H, Nishimura T. Int Immunol; 2007 Mar; 19(3):249-56. PubMed ID: 17229818 [Abstract] [Full Text] [Related]
10. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells. Wei H, Zheng X, Lou D, Zhang L, Zhang R, Sun R, Tian Z. Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292 [Abstract] [Full Text] [Related]
11. Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells. Zhang Q, Jang TL, Yang X, Park I, Meyer RE, Kundu S, Pins M, Javonovic B, Kuzel T, Kim SJ, Van Parijs L, Smith N, Wong L, Greenberg NM, Guo Y, Lee C. Prostate; 2006 Feb 15; 66(3):235-47. PubMed ID: 16173028 [Abstract] [Full Text] [Related]
12. Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation. Ye Z, Tang C, Xu S, Zhang B, Zhang X, Moyana T, Yang J, Xiang J. Cell Mol Immunol; 2007 Aug 15; 4(4):277-85. PubMed ID: 17764618 [Abstract] [Full Text] [Related]
13. The kinetics of cytokine production and CD25 expression by porcine lymphocyte subpopulations following exposure to classical swine fever virus (CSFV). Suradhat S, Sada W, Buranapraditkun S, Damrongwatanapokin S. Vet Immunol Immunopathol; 2005 Jul 15; 106(3-4):197-208. PubMed ID: 15963818 [Abstract] [Full Text] [Related]
14. Sustained antigen-specific antitumor recall response mediated by gene-modified CD4+ T helper-1 and CD8+ T cells. Moeller M, Kershaw MH, Cameron R, Westwood JA, Trapani JA, Smyth MJ, Darcy PK. Cancer Res; 2007 Dec 01; 67(23):11428-37. PubMed ID: 18056471 [Abstract] [Full Text] [Related]
18. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model. Chang CY, Lee J, Kim EY, Park HJ, Kwon CH, Joh JW, Kim SJ. BMC Cancer; 2007 May 23; 7():87. PubMed ID: 17519043 [Abstract] [Full Text] [Related]
19. Intratumor gene expression after adoptive immunotherapy in a murine tumor model. Regulation of messenger RNA levels associated with the differential expansion of tumor-infiltrating lymphocytes. Evans R, Kamdar SJ, Duffy T, Edison L. J Immunol; 1993 Jan 01; 150(1):177-84. PubMed ID: 8417123 [Abstract] [Full Text] [Related]